Retraction: HPV16 E7-Dependent Transformation Activates NHE1 through a PKA-RhoA-Iinduced Inhibition of p38alpha (PLoS ONE (2008) 3:10 (e3529) DOI: 10.1371/journal.pone.0003529);HPV16 E7-dependent transformation activates NHE1 through a PKA-RhoA-induced inhibition of p38alpha

PLoS ONE

Volumn 3, Issue 10, 2008, Pages

  Cardone, Rosa A ^a   Busco, Giovanni ^a   Greco, Maria R ^a   Bellizzi, Antonia ^b   Accardi, Rosita ^c   Cafarelli, Antonella ^a   Monterisi, Stefania ^a   Carratù, Pierluigi ^a   Casavola, Valeria ^a   Paradiso, Angelo ^b   Tommasino, Massimo ^c   Reshkin, Stephan J ^a  

^a UNIVERSITY OF BARI   (Italy)

^b NATIONAL CANCER INSTITUTE GIOVANNI PAOLO II   (Italy)

^c INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

Author keywords

[No Author keywords available]

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE 14; PROTEIN E7; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; SMALL INTERFERING RNA; SODIUM PROTON EXCHANGE PROTEIN 1; CATION TRANSPORT PROTEIN; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; ONCOGENE PROTEIN E7, HUMAN PAPILLOMAVIRUS TYPE 16; ONCOPROTEIN; SLC9A1 PROTEIN, HUMAN; SODIUM PROTON EXCHANGE PROTEIN; STRESS ACTIVATED PROTEIN KINASE; UNCLASSIFIED DRUG;

ARTICLE; CARCINOGENESIS; CELL TRANSFORMATION; CONTROLLED STUDY; DNA FLANKING REGION; ENZYME ACTIVITY; GENE ACTIVATION; GENE MUTATION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 16; MALIGNANT TRANSFORMATION; ONCOGENE; PHENOTYPE; PROTEIN PHOSPHORYLATION; RECEPTOR DOWN REGULATION; RECEPTOR UPREGULATION; RNA INTERFERENCE; SIGNAL TRANSDUCTION; ANIMAL; CELL CULTURE; CELL STRAIN 3T3; DOWN REGULATION; DRUG ANTAGONISM; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MOUSE; PHYSIOLOGY; TIME; VIRUS CELL TRANSFORMATION;

HUMAN PAPILLOMAVIRUS TYPE 16; MUS MUSCULUS;

ANIMALS; CATION TRANSPORT PROTEINS; CELL TRANSFORMATION, VIRAL; CELLS, CULTURED; CYCLIC AMP; CYCLIC AMP-DEPENDENT PROTEIN KINASES; DOWN-REGULATION; GENE EXPRESSION REGULATION, VIRAL; HUMANS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MICE; MITOGEN-ACTIVATED PROTEIN KINASE 14; NIH 3T3 CELLS; ONCOGENE PROTEINS, VIRAL; RHOA GTP-BINDING PROTEIN; SIGNAL TRANSDUCTION; SODIUM-HYDROGEN ANTIPORTER; TIME FACTORS;

EID: 55849138344     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0218402     Document Type: Erratum

References (67)

1. Hanahan D, Weinberg RA (2000) The hallmarks of cancer. Cell 100(1): 57-70.
2. Harguindey S, Orive G, Luis Pedraz J, Paradiso A, Reshkin SJ (2005) The role of pH dynamics and the Na+/H+ antiporter in the etiopathogenesis and treatment of cancer. Two faces of the same coin-one single nature. Biochim Biophys Acta 1756(1): 1-24.
3. Fang JS, Gillies RD, Gatenby RA (2008) Adaptation to hypoxia and acidosis in carcinogenesis and tumor progression. Semin Cancer Biol 18(5): 330-337.
4. Khavari TA, Rinn J (2007) Ras/Erk MAPK signaling in epidermal homeostasis and neoplasia. Cell Cycle 6(23): 2928-2931.
5. Cuevas BD, Abell AN, Johnson GL (2007) Role of mitogen-activated protein kinase kinase kinases in signal integration. Oncogene 26(22): 3159-3171.
6. Raman M, Chen W, Cobb MH (2007) Differential regulation and properties of MAPKs. Oncogene 26(22): 3100-3112.
7. Hui L, Bakiri L, Stepniak E, Wagner EF (2007) p38alpha: A Suppressor of Cell Proliferation and Tumorigenesis. Cell Cycle 6: 2429-2433.
8. Ventura JJ, Tenbaum S, Perdiguero E, Huth M, Guerra C (2007) p38alpha MAP kinase is essential in lung stem and progenitor cell proliferation and differentiation. Nature Genetics 39: 750-758.
9. Aguirre-Ghiso JA, Ossowski A, Rosenbaum SK (2004) Green fluorescent protein tagging of extracellular signal-kinase and p38 pathways reveals novel dynamics of pathway activation during primary and metastatic growth. Cancer Res 64: 7336-7345.
10. Jia Z, Vadnais J, Lu ML, Noel J, Nabi IR (2006) Rho/ROCK-dependent pseudopodial protrusion and cellular blebbing are regulated by p38 MAPK in tumour cells exhibiting autocrine c-Met activation. Biol Cell 98: 337-351.
11. Cardone RA, Bagorda A, Bellizzi A, Busco G, Guerra L, et al. (2005) Protein kinase A gating of a pseudopodial-located RhoA/ROCK/p38/NHE1 signal module regulates invasion in breast cancer cell lines. Mol Biol Cell 16(7): 3117-3127.
12. Cardone RA, Bellizzi A, Busco G, Weinman EJ, Dell'Aquila ME, et al. (2007) The NHERF1 PDZ2 domain regulates PKA-RhoA-p38-mediated NHE1 activation and invasion in breast tumor cells. Mol Biol Cell 18(5): 1768-1780.
13. Bulavin DV, Fornace AJ Jr (2004) p38 MAP Kinase's emerging role as a tumor suppressor. Adv Cancer Res 92: 95-118.
14. Bulavin DV, Phillips C, Nannenga B, Timofeev O, Donehower LA, et al. (2004) Inactivation of the Wip1 phosphatase inhibits mammary tumorigenesis through p38 MAPK-mediated activation of the p16(Ink4a)-p19(Arf) pathway. Nat Genet 36: 343-350.
15. Xia Z, Dickens M, Raingeaud J, Davis RJ, Greenberg ME (1995) Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science 270: 1326-1331.
16. Kennedy NJ, Cellurale C, Davis RJ (2007) A radical role for p38 MAPK in tumor initiation. Cancer Cell 11: 101-103.
17. Han J, Sun P (2007) The pathways to tumor suppression via route p38. Trends Biochem Sci 32: 364-371.
18. Aguirre-Ghiso JA (2007) Models, mechanisms and clinical evidence for cancer dormancy. Nat Rev Cancer 7: 834-846.
19. Bradham C, McClay DR (2006) p38 MAPK in development and cancer. Cell Cycle 5(8): 824-828.
20. Wu R, Coniglio SJ, Chan A, Symons MH, Steinberg BM (2007) Up-regulation of Rac1 by epidermal growth factor mediates COX-2 expression in recurrent respiratory papillomas. Mol Med 13(3-4): 143-150.
21. Reshkin SJ, Bellizzi A, Cardone RA, Tommasino M, Casavola V, Paradiso A (2003) Paclitaxel induces apoptosis via PKA- and p38 MAP-dependent inhibition of the Na+/H+ exchanger NHE1 in human breast cancer. Clinical Cancer Res 9: 2366-2373.
22. Cuadrado A, Lafarga V, Cheung PC, Dolado I, Llanos S, et al. (2007) A new p38 MAP kinase-regulated transcriptional coactivator that stimulates p53-dependent apoptosis. EMBO J 26: 2115-2126.
23. Kralova J, Dvorak M, Koc M, Kral V (2008) p38 MAPK plays an essential role in apoptosis induced by photoactivation of a novel ethylene glycol porphyrin derivative. Oncogene 27: 3010-3020.
24. Hui L, Bakiri L, Mairhorfer A, Schweifer N, Haslinger C, et al. (2007) p38alpha suppresses normal and cancer cell proliferation by antagonizing the JNK-c-Jun pathway. Nature Genetics 39: 741-749.
25. Kristelly R, Gao G, Tesmer JJ (2004) Structural determinants of RhoA binding and nucleotide exchange in leukemia-associated Rho guanine-nucleotide exchange factor. J Biol Chem 279(45): 47352-47362.
26. Wang DA, Sebti SM (2005) Palmitoylated cysteine 192 is required for RhoB tumor-suppressive and apoptotic activities. J Biol Chem 280(19): 19243-19249.
27. Fritz G, Kaina B (2006) Rho GTPases: promising cellular targets for novel anticancer drugs. Curr Cancer Drug Targets 6: 1-14.
28. Lovett FA, Gonzalez I, Salih DA, Cobb LJ, Tripathi G, et al. (2006) Convergence of Igf2 expression and adhesion signalling via RhoA and p38 MAPK enhances myogenic differentiation. J Cell Sci 119(Pt 23): 4828-4840.
29. Vanni C, Mancini P, Ottaviano C, Ognibene M, Parodi A, et al. (2007) Galpha13 regulation of proto-Dbl signaling. Cell Cycle 6: 2058-2070.
30. Yamashita M, Otsuka F, Mukai T, Otani H, Inagaki K, et al. (2008) Simvastatin antagonizes tumor necrosis factor-alpha inhibition of bone morphogenetic proteins-2-induced osteoblast differentiation by regulating Smad signaling and Ras/Rho-mitogen-activated protein kinase pathway. J Endocrinol 196(3): 601-613.
31. Zhou S, Bachem MG, Seufferlein T, Li Y, Gross HJ, Schmelz A (2008) Low intensity pulsed ultrasound accelerates macrophage phagocytosis by a pathway that requires actin polymerization, Rho, and Src/MAPKs activity. Cell Signal 20(4): 695-704.
32. Dreissigacker U, Mueller MS, Siegert P, Genze F, Gierschik P, Giehl K (2006) Oncogenic K-Ras down-regulates Rac1 and RhoA activity and enhances migration and invasion of pancreatic carcinoma cells through activation of p38. Cellular Signalling 18: 1156-1168.
33. Charette ST, McCance DJ (2007) The E7 protein from human papillomavirus type 16 enhances keratinocyte migration in an Akt-dependent manner. Oncogene 26: 7386-7390.
34. Farrow B, Rychahou P, Murillo C, O'connor KL, Iwamura T, Evers BM (2003) Inhibition of pancreatic cancer cell growth and induction of apoptosis with novel therapies directed against protein kinase A. Surgery 134: 197-205.
35. Mantovani G, Lania AG, Bondioni S, Peverelli E, Pedroni C, et al. (2008) Different expression of protein kinase A (PKA) regulatory subunits in cortisol-secreting adrenocortical tumors: relationship with cell proliferation. Exp Cell Res 314(1): 123-130.
36. Robinson-White AJ, Hsiao HP, Leitner WW, Greene E, Bauer A, et al. (2008) Protein kinase A-independent inhibition of proliferation and induction of apoptosis in human thyroid cancer cells by 8-Cl-adenosine. J Clin Endocrinol Metab 93(3): 1020-1029.
37. Mantovani G, Bondioni S, Lania AG, Rodolfo M, Peverelli E, et al. (2008) High expression of PKA regulatory subunit 1A protein is related to proliferation of human melanoma cells. Oncogene 27(13): 1834-1843.
38. Kim SY, Seo M, Kim Y, Lee YI, Oh JM, et al. (2008) Stimulatory heterotrimeric GTP-binding protein inhibits hydrogen peroxide-induced apoptosis by repressing BAK induction in SH-SY5Y human neuroblastoma cells. J Biol Chem 283(3): 1350-1561.
39. Dohi T, Xia F, Altieri DC (2007) Compartmentalized phosphorylation of IAP by protein kinase A regulates cytoprotection. Mol Cell 27(1): 17-28.
40. Paradiso A, Cardone RA, Bellizzi A, Bagorda A, Guerra L, et al. (2004) The Na+- H+ exchanger-1 induces cytoskeletal changes involving reciprocal RhoA and Rac1 signaling, resulting in motility and invasion in MDA-MB-435 cells. Breast Cancer Res 6(6): R616-R6128.
41. Kobayashi Y, Mizoguchi T, Take I, Kurihara S, Udagawa N, Takahashi N (2005) Prostaglandin E2 enhances osteoclastic differentiation of precursor cells through protein kinase A-dependent phosphorylation of TAK1. J Biol Chem 280(12): 11395-11403.
42. Hsiao PW, Chang CC, Liu HF, Tsai CM, Chiu TH, Chao JI (2007) Activation of p38 mitogen-activated protein kinase by celecoxib oppositely regulates survivin and gamma-H2AX in human colorectal cancer cells. Toxicol Appl Pharmacol 222(1): 97-104.
43. Leone V, di Palma A, Ricchi P, Acquaviva F, Giannouli M, et al. (2007) PGE2 inhibits apoptosis in human adenocarcinoma Caco-2 cell line through Ras-PI3K association and cAMP-dependent kinase A activation. Am J Physiol Gastrointest Liver Physiol 293(4): G673-G681.
44. Qiao J, Huang F, Lum H (2003) PKA inhibits RhoA activation: a protection mechanism against endothelial barrier dysfunction. Am J Physiol Lung Cell Mol Physiol 284(6): L972-L980.
45. Murthy KS, Zhou H, Grider JR, Makhlouf GM (2003) Inhibition of sustained smooth muscle contraction by PKA and PKG preferentially mediated by phosphorylation of RhoA. Am J Physiol 284: G1006-G1016.
46. Lang P, Gesbert F, Delespine-Carmagnat M, Stancou R, Pouchelet M, Bertoglio J (1996) Protein kinase A phosphorylation of RhoA mediates the morphological and functional effects of cyclic AMP in cytotoxic lymphocytes. EMBO J 15(3): 510-519.
47. Zur Hausen H (2002) Papillomaviruses and cancer: from basic studies to clinical application. Nat Rev Cancer 2: 342-350.
48. Reshkin SJ, Bellizzi A, Caldeira S, Albarani V, Malanchi I (2000) Na+/H+ exchanger-dependent intracellular alkalinization is an early event in malignant transformation and plays an essential role in the development of subsequent transformation-associated phenotypes. FASEB 14(14): 2185-2197.
49. Ruesch MN, Stubenrauch F, Laimins LA (1998) Activation of papillomavirus late gene transcription and genome amplification upon differentiation in semisolid medium is coincident with expression of involucrin and transglutaminase but not keratin-10. J Virol 72: 5016-5024.
50. Dü rst M, Seagon S, Wanschura S, zur Hausen H, Bullerdiek J (1995) Malignant progression of an HPV16-immortalized human keratinocyte cell line (HPKIA) in vitro. Cancer Genet Cytogenet 85: 105-112.
51. Zaccolo M, Magalhães P, Pozzan T (2002) Compartmentalisation of cAMP and Ca(2+) signals. Curr Opin Cell Biol 14(2): 160-166.
52. Mansur CP, Androphy EJ (1993) Cellular transformation by papillomavirus oncoproteins. Biochim Biophys Acta 1155: 323-345.
53. Banks L, Edmonds C, Vousden K (1990) Ability of the HPV16 E7 protein to bind RB and induce DNA synthesis is not sufficient for efficient transforming activity in NIH3T3 cells. Oncogene 5: 1383-1389.
54. Phelps WC, Münger K, Yee CL, Barnes JA, Howley PM (1992) Structure-Function Analysis of the Human Papillomavirus Type 16 E7 Oncoprotein. J Virol 66: 2418-2427.
55. Yaqub S, Henjum K, Mahic M, Jahnsen FL, Aandahl EM, Bjørnbeth BA, Taskén K (2008) Regulatory T cells in colorectal cancer patients suppress anti-tumor immune activity in a COX-2 dependent manner. Cancer Immunol Immunother 57(6): 813-821.
56. Ahn BH, Park MH, Lee YH, Kwon TK, Min do S (2007) Up-regulation of cyclooxygenase-2 by cobalt chloride-induced hypoxia is mediated by phospholipase D isozymes in human astroglioma cells. Biochim Biophys Acta 1773(12): 1721-1723.
57. Chen D, Reierstad S, Lin Z, Lu M, Brooks C, et al. (2007) Prostaglandin E(2) induces breast cancer related aromatase promoters via activation of p38 and c-Jun NH(2)-terminal kinase in adipose fibroblasts. Cancer Res 67(18): 8914-8922.
58. Ellerbroek SM, Wennerberg K, Burridge K (2003) Serine phosphorylation negatively regulates RhoA in vivo. J Biol Chem 278(21): 19023-19031.
59. Kimura K, Tsuji T, Takada Y, Miki T, Narumiya S (2000) Accumulation of GTP-bound RhoA during cytokinesis and a critical role of ECT2 in this accumulation. J Biol Chem 275(23): 17233-17236.
60. Yoshizaki H, Ohba Y, Parrini MC, Dulyaninova NG, Bresnick AR (2004) Cell type-specific regulation of RhoA activity during cytokinesis. J Biol Chem 279(43): 44756-44762.
61. Forget MA, Desrosiers RR, Gingras D, Béliveau R (2002) Phosphorylation states of Cdc42 and RhoA regulate their interactions with Rho GDP dissociation inhibitor and their extraction from biological membranes. Biochem J 361(Pt 2): 243-54.
62. Dhillon AS, Hagan S, Rath O, Kolch W (2007) MAP kinase signalling pathways in cancer. Oncogene 26(22): 3279-3290.
63. Mao X, Bravo IG, Cheng H, Alonso A (2004) Multiple independent kinase cascades are targeted by hyperosmotic stress but only one activates stress kinase p38. Exp Cell Res 292(2): 304-311.
64. Moule SK, Denton RM (1998) The activation of p38 MAPK by the beta-adrenergic agonist isoproterenol in rat epididymal fat cells. FEBS Lett 439(3): 287-290.
65. Yano M, Matsumura T, Senokuchi T, Ishii N, Murata Y, et al. (2007) Statins activate peroxisome proliferator-activated receptor gamma through extracellular signal-regulated kinase 1/2 and p38 mitogen-activated protein kinase-dependent cyclooxygenase-2 expression in macrophages. Circ Res 100(10): 1442-1451.
66. Zeidan A, Javadov S, Chakrabarti S, Karmazyn M (2008) Leptin-induced cardiomyocyte hypertrophy involves selective caveolae and RhoA/ ROCK-dependent p38 MAPK translocation to nuclei. Cardiovasc Res 77(1): 64-72.
67. Townsend TA, Wrana JL, Davis GE, Barnett JV (2008) Transforming Growth Factor-{beta}-stimulated Endocardial Cell Transformation Is Dependent on Par6c Regulation of RhoA. J Biol Chem 283: 13834-13841.